Skip to main content
. Author manuscript; available in PMC: 2014 Jan 1.
Published in final edited form as: Breast Cancer Res Treat. 2012 Dec 18;137(2):431–448. doi: 10.1007/s10549-012-2377-x

Fig. 1.

Fig. 1

Primary breast cancer xenograft tumor contains ER, PR, HER2, CD44, and AR. Breast cancer cells from a pleural effusion were grown in immunocompromised mice supplemented with estradiol for 12 weeks. H&E and immunostaining for ER, PR, HER2, CD44, and AR was performed as described